Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?

about

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?

Item

http://www.wikidata.org/entity/Q36089078

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Comparing the results of bisph ...... a case of apples and oranges?

@ast

Comparing the results of bisph ...... a case of apples and oranges?

@en

type

Item

label

Comparing the results of bisph ...... a case of apples and oranges?

@ast

Comparing the results of bisph ...... a case of apples and oranges?

@en

prefLabel

Comparing the results of bisph ...... a case of apples and oranges?

@ast

Comparing the results of bisph ...... a case of apples and oranges?

@en

P1476

Comparing the results of bisph ...... a case of apples and oranges?

@en

P2093

G Dranitsaris

http://www.w3.org/2001/XMLSchema#string

M C Gainford

http://www.w3.org/2001/XMLSchema#string

M Clemons

http://www.w3.org/2001/XMLSchema#string

M Vanhuyse

http://www.w3.org/2001/XMLSchema#string

W Ooi

http://www.w3.org/2001/XMLSchema#string

P2860

Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer

Recent developments in bisphosphonates for patients with metastatic breast cancer.

Analysis of skeletal-related events in breast cancer and response to therapy.

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer.

Do physicians follow systemic treatment and funding policy guidelines?

Spinal cord compression in breast cancer: a review of 70 cases.

The clinical course of bone metastases from breast cancer.

Can bone markers guide more effective treatment of bone metastases from breast cancer?

Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.

P304

187-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22792016

http://www.w3.org/2001/XMLSchema#string

P932

3394602

http://www.w3.org/2001/XMLSchema#string